Table 1.

Summary of presumptive ESBL‐, and AmpC‐producing Salmonella spp. from meat and indicator E. coli isolates from caecal samples collected within the routine monitoring in 2017

Matrix	Presumptive ESBL and/or AmpC producersa	Presumptive ESBL producersa	Presumptive AmpC producersc	Presumptive ESBL + AmpC producersd	Presumptive CP producers
	n (%R)	n (%R)b	n (%R)	n (%R)	n (%R)e
Salmonella
Humans (N = 8,020, 12 MSs)	77 (1.0)	62 (0.8)	12 (0.1)	3 (0.04)	0f
Pig meat (N = 954, 22 MSs)	5 (0.5)	2 (0.2)	3 (0.3)	0	0
Bovine meat (N = 82, 7 MSs)	0	0	0	0	0
E. coli
Fattening pigs (N = 4,205, 28 MSs)	52 (1.2)	38 (0.9)	14 (0.3)	0	0
Calves, < 1 y. old (N = 1,893, 10 MSs)	26 (1.4)	25 (1.3)	5 (0.3)	4 (0.2)	0

N: Total of isolates reported for this monitoring by the MSs; n: number of the isolates resistant; % R: percentage of resistant isolates; ESBL: extended‐spectrum beta‐lactamase; MS: EU Member States.

^aIsolates exhibiting only ESBL‐ and/or only AmpC‐ and/or ESBL + AmpC phenotype.

^bIsolates exhibiting an ESBL‐ and ESBL/AmpC phenotype.

^cIsolates exhibiting an AmpC‐ and ESBL/AmpC phenotype.

^dIsolates exhibiting only ESBL/AmpC phenotype.

^eIsolates exhibiting CP phenotype.

^fTwo isolates reported as clinically susceptible to meropenem were later confirmed to carry carbapenemase genes.